Related references
Note: Only part of the references are listed.A Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of 5-Fluorouracil Degradation Rate by Intact Peripheral Blood Mononuclear Cells
Alfonso M. Lostia et al.
THERAPEUTIC DRUG MONITORING (2009)
Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin
Andre B. P. van Kuilenburg et al.
EUROPEAN JOURNAL OF CANCER (2007)
Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines
K Miyazaki et al.
JOURNAL OF GASTROENTEROLOGY (2006)
The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity:: Pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil
LK Mattison et al.
CLINICAL CANCER RESEARCH (2006)
Dihydropyrimidine dehydrogenase activity in 150 healthy Japanese volunteers and identification of novel mutations
K Ogura et al.
CLINICAL CANCER RESEARCH (2005)
Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test
LK Mattison et al.
CLINICAL CANCER RESEARCH (2004)
Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers
H Baba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients
A Di Paolo et al.
THERAPEUTIC DRUG MONITORING (2002)
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics
G Milano et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes:: application to measurement of dihydropyrimidine dehydrogenase activity
R Déporte-Féty et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans
R Guimbaud et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
